2-(6-Aryl-3(Z)-hexen-1,5-diynyl)anilines as a New Class of Potent Antitubulin Agents

Journal of Medicinal Chemistry
2008.0

Abstract

Compounds 2a- h and 6 displayed significant GI 50 values of 10(-7)-10(-6) M against various cancer cell lines. Of these compounds, 2-(6-(2-trifluoromethylphenyl))-3(Z)-hexen-1,5-diynyl)aniline (2c) showed the most potent growth inhibition activity. Compound 2c also arrested cancer cells in the G2/M phase and in low concentration reduced a significant percentage of MDA-MB-231/ATCC breast cancer tetraploid cells. In addition to the G2/M block, compound 2c caused microtubule depolymerization and induced apoptosis via activation of the caspase family.

Knowledge Graph

Similar Paper

2-(6-Aryl-3(Z)-hexen-1,5-diynyl)anilines as a New Class of Potent Antitubulin Agents
Journal of Medicinal Chemistry 2008.0
Design, synthesis, biological evaluation and molecular modeling studies of 1-aryl-6-(3,4,5-trimethoxyphenyl)-3( Z )-hexen-1,5-diynes as a new class of potent antitumor agents
European Journal of Medicinal Chemistry 2013.0
2-Anilinonicotinyl linked 1,3,4-oxadiazole derivatives: Synthesis, antitumour activity and inhibition of tubulin polymerization
MedChemComm 2011.0
(Z)-1-Aryl-3-arylamino-2-propen-1-ones, Highly Active Stimulators of Tubulin Polymerization: Synthesis, Structure–Activity Relationship (SAR), Tubulin Polymerization, and Cell Growth Inhibition Studies
Journal of Medicinal Chemistry 2012.0
7-Aroyl-aminoindoline-1-sulfonamides as a Novel Class of Potent Antitubulin Agents
Journal of Medicinal Chemistry 2006.0
Isolation and Identification of the Novel Tubulin Polymerization Inhibitor Bifidenone
Journal of Natural Products 2017.0
Synthesis of terphenyl benzimidazoles as tubulin polymerization inhibitors
European Journal of Medicinal Chemistry 2012.0
Synthetic 2-Aroylindole Derivatives as a New Class of Potent Tubulin-Inhibitory, Antimitotic Agents
Journal of Medicinal Chemistry 2001.0
2-Arylaminobenzothiazole-arylpropenone conjugates as tubulin polymerization inhibitors
MedChemComm 2017.0
Design, Synthesis, and Biological Evaluation of (E)-N-Aryl-2-arylethenesulfonamide Analogues as Potent and Orally Bioavailable Microtubule-Targeted Anticancer Agents
Journal of Medicinal Chemistry 2013.0